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A self-assembling amphiphilic peptide
nanoparticle for the eﬃcient entrapment
of DNA cargoes up to 100 nucleotides in length†
Shabnam Tarvirdipour,ab Cora-Ann Schoenenberger,a Yaakov Benenson*b and
Cornelia G. Palivan *a
To overcome the low eﬃciency and cytotoxicity associated with most non-viral DNA delivery systems
we developed a purely peptidic self-assembling system that is able to entrap single- and double-
stranded DNA of up to 100 nucleotides in length. (HR)3gT peptide design consists of a hydrophilic
domain prone to undergo electrostatic interactions with DNA cargo, and a hydrophobic domain at a
ratio that promotes the self-assembly into multi-compartment micellar nanoparticles (MCM-NPs). Self-
assembled (HR)3gT MCM-NPs range between 100 to 180 nm which is conducive to a rapid and eﬃcient
uptake by cells. (HR)3gT MCM-NPs had no adverse eﬀects on HeLa cell viability. In addition, they exhibit
long-term structural stability at 4 1C but at 37 1C, the multi-micellar organization disassembles overtime
which demonstrates their thermo-responsiveness. The comparison of (HR)3gT to a shorter, less charged
H3gT peptide indicates that the additional arginine residues result in the incorporation of longer DNA
segments, an improved DNA entrapment eﬃciency and an increase cellular uptake. Our unique non-
viral system for DNA delivery sets the stage for developing amphiphilic peptide nanoparticles as
candidates for future systemic gene delivery.
Introduction
Gene therapy depends on viral and non-viral delivery systems to
ferry therapeutic nucleic acids into target cells.1,2 While there
are a few viral-based gene therapy products approved by
regulatory agencies,3,4 there are numerous disadvantages asso-
ciated with a viral strategy such as high immunogenicity,
mutagenicity, limitation in size of transgenic DNA, low avail-
ability, and high development and manufacturing cost.5 These
drawbacks led to a boost of non-viral systems for DNA delivery
including some that are currently at various stages of clinical
trials.6–8 The advantages of non-viral DNA delivery systems
include lower immunogenicity and toxicity, better cell specificity,
extensive flexibility in design with the option of large-scale
production at comparatively low cost.9,10 So far, several types of
nanoparticles have been studied for DNA delivery, for example
quantum dots, carbon nanotubes, gold nanoparticles, silica nano-
particles, and polymer-based and lipid-based nanoparticles.11
Peptides as non-viral gene delivery vectors are particularly attrac-
tive as they offer nearly limitless design options, higher bio-
compatibility and biodegradability, high binding affinities and
increased cellular penetration.12,13 Consistently, the comprehen-
sive study of DNA/peptide complexes and conjugated peptides
with regard to cellular targeting and fusogenic function corro-
borate their exceptional properties compared to other non-viral
gene delivery systems.14 Moreover, nanovesicles assembled from
branched amphipathic peptides that served as cationic nuclea-
tion centers around which DNA winds were reported to deliver
plasmid DNA in vivo and in vitro.15 However, studies involving
the self-assembly of supramolecular nanoparticles from pure
peptides for DNA delivery are rare16,17 and to best of our
knowledge, parameters conductive to the entrapment and
delivery of DNA molecules have so far not been systematically
investigated.
A large number of non-viral gene-therapy systems focus
on the delivery of antisense oligonucleotides (ASOs).18–21 These
20 to 40 nucleotide single-stranded DNAs (ssDNAs) can be
designed to mediate target RNA degradation, block the trans-
lation of a specific RNA, and modify RNA splicing.22 Nevertheless,
pro-inflammatory effects, inadequate pharmacokinetic properties
such as high degradation rates and short half-lives, off-target
effects, and preclinical toxicological challenges are associated
with these systems and represent hurdles that impede their
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clinical application.23 One option to sidestep drawbacks of
ASOs is to entrap entire genes. On the other hand, many non-
viral nanosystems that are able to deliver entire plasmid DNA
encoding various genes have been reported.24–27 However,
these delivery systems are largely based on conjugation or
complex formation of the DNA with lipids,28,29 polymers,30,31
and peptides32–35 rather than on the directed self-assembly of
supramolecular nanostructures. The ability to entrap DNA
sequences larger than 50 nucleotides in length, either single-
or double-stranded, by self-assembly of peptides alone has not
been systematically explored so far. By taking advantage of the
concept of self-assembly rather than depending on tedious
chemical reactions for producing supramolecular assemblies,
several aspects of a rational design are fulfilled. Self-assembly
allows for the specific selection of starting components and
a subsequent optimization by adapting the building blocks
to produce tailored, well-defined structures that are easy to
handle.36–40 Amphipathic peptides are emerging as suitable
candidates for fabricating well-ordered nanostructures.41–47
To take advantage of the vector properties oﬀered by peptides
and at the same time start closing the gap in cargo size between
ASOs and entire genes, we intended to establish a purely peptidic,
self-assembling delivery system that lends itself to the incorpora-
tion of single- and double-stranded DNA segments that are
larger than the average ASO. Here, we report a novel amphi-
philic peptide henceforth called (HR)3gT that is designed to
self-assemble into multi-compartment micellar nanoparticles
(MCM-NPs). Qualitative and quantitative analysis of amphiphilic
peptide self-assembly leading to multi-compartment micellar
nanoparticles with detailed statistical data of their inner structure
was reported by de Bruyn Ouboter.48 One of the parameters that
principally governs the self-assembly of amphiphilic peptides is
hydrophilic–hydrophobic balance.35,49 Therefore, our sequence
modifications to the H3gT peptide were designed to keep the
hydrophobic to hydrophilic weight ratio relatively constant.
We significantly modified the design of a previously published
amphiphilic H3gT peptide that forms MCM-NPs50 by the addi-
tion of charged amino acid residues to allow for more electro-
static interactions between peptide and DNA. The extension of
the hydrophilic peptide domain was accompanied by an increase
of the hydrophobic domain to sustain the peptide’s ability to self-
assemble into the desired nanoparticle architecture. We address
how changes in length and type (single-stranded versus double-
stranded) of DNA sequences affect the self-assembly process of
peptides. First and foremost, a detailed understanding of the
physicochemical properties of the peptidic nanoparticles that
are conducive to the incorporation of longer DNA sequences is
required.
The impact of the aforementioned modifications on (HR)3gT
self-assembly was systematically analysed in the absence and
presence of single- and double-stranded DNA (ssDNA/dsDNA) of
22 and 100 nucleotide length. In particular, we examined how
compared to H3gT, the modified physicochemical properties of
(HR)3gT aﬀected the loading eﬃciency of a 22-nucleotide ssDNA.
By dissecting the relationship between the type and length of the
DNA sequence and the MCM-NP formation, we demonstrate that
(HR)3gT nanoparticles can accommodate longer DNA segments
as payloads. While emphasizing the importance of the physico-
chemical properties of peptide nanoparticles in generating safe
and eﬃcient DNA-delivery systems, our results pave the way to
incorporate protein-coding sequences in peptide assemblies as
an eﬃcient approach to non-viral gene-based therapy.
Materials and methods
Solvents and reagents
Solvents and reagents were purchased from Sigma-Aldrich
unless otherwise specified. Triisopropylsilane, piperidine and
N,N0-diisopropylcarbodiimide (DIC) were of synthesis grade.
Rink Amide AM resin (0.71 mmol g1) and Fmoc-Trp(Boc)-OH
were purchased from IRIS Biotech GmbH. All other Fmoc-
protected amino acids and ethyl cyano(hydroxyimino)acetate
(Oxyma Pure) were purchased from Novabiochem. Dimethyl-
formamide (DMF) was purchased from J.T. Baker. Dichloro-
methane (DCM) and acetonitrile (ACN) were purchased from
VWR chemical. Solvent exchange was performed in dialysis
tubes from Spectrum Laboratories (cellulose ester, MWCO
500–1000 Da, 3.2 cm mL1). Atto550 was purchased from
ATTO-TEC GmbH. Atto550-labeled, 22 nucleotide (nt) and
100 nt DNA and their unlabelled complementary stands were
purchased from Microsynth. Fetal calf serum (FCS) and phos-
phate buffer saline (PBS) was purchased from BioConcept.
Live cell imaging solution was obtained from Thermo Fisher
Scientific. Dulbecco’s modified Eagle’s medium (DMEM), Opti-
MEM, and pen/strep were obtained from Gibco life technologies.
CellTiter 96 AQueous One Solution Cell Proliferation Assay (MTS)
was purchased from Promega.
Peptide synthesis and purification
(HR)3gT peptide consists of nineteen amino acids (AA), H2N-[H-
R]3-[W-DL]6-W-NH2, (with DL = D-leucine) and H3gT of 10 AA,
H2N-[H]3-[W-DL]3-W-NH2, as previously reported.
50 The (HR)3gT
and H3gT peptides were synthesized using Liberty Bluet auto-
mated microwave peptide synthesizer (CEM, Kamp-Lintfort,
Germany). The synthesis of both peptides was performed on
a rink amide resin using standard fluorenylmethoxycarbonyl
(Fmoc) solid phase peptide synthesizer chemistry and DIC/
OXYMA coupling protocols. After completing synthesis in the
Liberty Bluet synthesizer, the peptidyl resin was collected and
washed alternatingly with DMF and dichloromethane. Peptides
were manually cleaved from the resin by 5 mL trifluoroacetic
acid (TFA) under gentle agitation over a period of 2 h at room
temperature in the presence of scavengers (standard cleavage
solution: TFA/triisopropylsilane (TIPS)/water 95 : 2.5 : 2.5). The
cleavage cocktail was filtered and the resin was washed with
1 mL cleavage solution. The peptides were precipitated from
the combined cleavage solution by the addition of 40 mL cold
diethyl ether and pelleted by centrifugation at 4500 rpm for
3 min at 4 1C. The pellet together with supernatant were
incubated at 20 1C for 1 h and again centrifuged under the
same conditions and supernatant was discarded. The pellet was
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dissolved in ACN/H2O (1 : 1) and TFA (0.05%, v/v) solution. The
crude peptide was filtered and lyophilized.
Purification of the crude (HR)3gT and H3gT peptide was
carried out by reversed phase high performance liquid chromato-
graphy (RP-HPLC) (Prominence 20A, Shimadzu, Japan) on a
C18-TSE (VDSpher OptiBio PUR 300 C18-TSE, 20  250 mm,
VDS Optilab, Germany) and a C18 (RP18e, 100 mm  10 mm,
Merck Chromolith, Germany) column, respectively. A mobile
phase of water and acetonitrile containing 0.1% TFA with a
gradient of 25–60% ACN over 30 min for (HR)3gT and 20–65%
ACN over 30 min for H3gT was used to separate peptides, and
purification was monitored at 280 nm. Purified peptides were
lyophilized and stored at 20 1C. The molecular mass of each
peptide was determined by PerSeptive Biosystems Voyager-DE-
PRO time-of-flight mass spectrometer (MALDI-TOF-MS) in
positive mode. Peptides were characterized by analytical high
performance liquid chromatography (HPLC) and (MALDI-TOF)
mass spectroscopy before and after purification.
Self-assembly of peptide MCM-NPs
For self-assembly of empty and DNA-loaded peptide nanoparticles,
a 1mgmL1 peptide stock solution was prepared in 50/50 ethanol/
water from the respective lyophilized peptide and filtered through
a 0.2 mm hydrophilic syringe filter. Self-assembly was achieved
via the solvent exchange method by dialysing the organic solvent
(ethanol) against Milli-Q H2O (Merck Millipore, Milli-Q Direct 8
water purification system). For loading nanoparticles with DNA,
the following synthetic DNA cargoes were prepared at a concen-
tration of 100 mM in water: 50Atto550-labeled 22 nt and 100 nt
single-stranded DNA (22 nt ssDNA/100 nt ssDNA), and 22 and
100 base pair double-stranded DNA (22 bp dsDNA/100 bp dsDNA)
with one 50Atto550-labeled strand (sequence data are provided
in Table S1, ESI†). In order to form DNA-loaded peptide nano-
particles, 100 mL of peptide stock solution were mixed with 3 mg of
DNA (100 mM solution). The DNA–peptide mixture was then
adjusted to a final volume of 500 mL in a final concentration
of 20%, 35%, or 50% ethanol, and then filled in a prewashed
500–1000 MWCO dialysis tube. The self-assembly was induced by
dialysis at 4 1C for approximately 20 h against three changes of 1 L
water. To prepare the control nanoparticles without DNA, peptide
solutions were diluted to a concentration of 0.2 mg mL1 in
corresponding final ethanol concentrations (20%, 35% or 50%)
and subsequently dialyzed under the same conditions.
Characterization of DNA-free and DNA-loaded peptide
MCM-NPs
Dynamic light scattering. The hydrodynamic mean diameter
(z-average) and polydispersity index of the peptide MCM-NPs
were determined by dynamic light scattering (DLS) at a wave-
length of 633 nm at 25 1C with an angle detection of y = 1731
using a Zeta Sizer Nano ZSP (Malvern Instruments Ltd, UK).
All measurements were performed in triplicate.
Zeta-potential. For measuring the zeta-potential by Zeta
Sizer Nano ZSP (Malvern Instruments Ltd, UK), 500 mL of
peptide MCM-NPs in water were added to a cuvette and the
zeta-potential recorded after each polyelectrolyte deposition.
Zeta potential data represent the mean of three consecutive
measurements.
Transmission electron microscopy. For transmission electron
microscopy (TEM), aliquots of self-assembled structures were
deposited on a glow-discharged, carbon-coated, parlodion-(2%
in n-butyl acetate) copper grid and adsorbed for 2 min. Excess
liquid was blotted with a filter paper and grids were negatively
stained for 10 s with 5 mL 2% uranyl acetate, washed 3 times with
water and dried. Grids were examined with a CM100 transmission
electron microscope (Philips, Eindhoven, The Netherlands)
operated at an accelerating voltage of 80 kV.
Nanoparticle tracking analysis. Nanoparticle tracking analysis
(NTA) was performed using a NanoSight NS 300 instrument
(NanoSight Ltd, Amesbury, UK) equipped with a 532 nm laser.
NTA software calculates the size based on tracking the Brownian
motion of the particles and using the velocity of the particle
movement to apply into the 2D Stokes–Einstein equation.
Self-assembled peptide nanoparticles were diluted 10-fold and
delivered to the viewing chamber using a 1 mL syringe. For
each measurement, three videos of 60 s were captured at room
temperature. Particle movement was analysed by the NTA software
(version 3.4, NanoSight) based on tracking each particle on a
frame-by-frame basis in order to give themean andmedian particle
size together with the estimated concentration of nanoparticles in
solution. To determine DNA loading efficiency, NTA data for each
Atto550-DNA loaded peptide NPs was recorded under scatter
and fluorescence mode. The NTA acquisition settings were kept
constant between measurements.
Fluorescence correlation spectroscopy. Fluorescence corre-
lation spectroscopy (FCS) experiments were performed at 20 1C
on a Zeiss LSM 880 laser-scanning microscope equipped with a
40 water immersion objective (C-Apochromat 40, NA 1.2)
(Carl Zeiss, Jena, Germany). For each measurement, 10 mL of
sample (Atto550-labeled DNA in solution and Atto550-DNA-
loaded peptide nanoparticles) were placed on a 22  50 mm
glass slide. Measurements were performed using a helium/
neon laser for 561 nm excitation, set at 0.25% laser power, a
488/561/633 main beam splitter (MBS), and a pinhole size of
40 mm.
Fluorescence signals were measured in a real time (5 s with
30 repetitions) and autocorrelation function was obtained by a
QuickFit 3.0 software calculator. For determining the DNA
entrapment in peptide MCM-NPs, experimental auto correla-
tion curves were fitted to a two-component model including
triplet state with a structural parameter of 5 (eqn (1)):51–53
G tð Þ ¼ 1þ 1þ T
1 Te
t=ttrip
 
 1
N
f1
1þ t
tD1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ R2 t
tD1
r þ f2
1þ t
tD2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ R2 t
tD2
r
0
BB@
1
CCA
(1)
where, tD1 and tD2 are the diffusion time and f1 and f2 are the
fraction of the corresponding component, Atto-550 labelled free
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DNA and entrapped DNA inside the peptide MCM-NPs,
respectively. T is the fraction of fluorophores in triplet state
with triplet time ttrip, N is the average number of particles in the
confocal volume and R is the structural parameter (fixed to 5).
For the three-dimensional (3-D) Gaussian-shaped observation
volume (Vobs), identical fluorescent species with the volume much
smaller than Vobs moving in and out of it and, autocorrelation
function (G(t)) determine with eqn (2):51–53
G tð Þ ¼ 1
N
1þ t
tD
 1
1þ r
l
 2 t
tD
  1=2
(2)
where r and l are the radial and axial length of the observation
volume, respectively. The diffusion time tD of the species can then
be related to the diffusion coefficient D by eqn (3):51–53
tD ¼ r
2
4D
(3)
With the diffusion coefficient of the fluorescent species and its
concentration (N/Vobs) in a diluted sample, finally the hydro-
dynamic radius (Rh) of the fluorescent species can be calculated
using the Stokes–Einstein equation.51–53
Rh ¼ kT
6pZD
(4)
where k is Boltzmann constant, T is temperature and Z is the
viscosity of the solution.
Thermo-responsiveness of DNA-free and DNA-loaded
peptide MCM-NPs. To analyze the thermosresponse of peptide
NPs, 25 mL of empty and DNA-loaded peptide nanoparticles
were mixed with 50 mL of PBS, pH 7.4, and incubated at 37 1C
for the times indicated. Nanoparticle morphology was examined
by TEM before incubation and at the time points indicated.
Cell culture. HeLa and histone H2B-GFP expressing HeLa
cell lines were cultured at 37 1C in DMEM supplemented with
10% FCS in a humidified atmosphere with 5% CO2.
MTS cell viability assay. Cell proliferation and cytotoxicity
assays were performed using tetrazolium compound based Cell
Titer 96s AQueous One Solution Cell Proliferation (MTS) assay
(Promega). MTS assay was performed according to the manu-
facturer’s instructions after 24 hours of treatment with peptide
nanoparticles. In brief, HeLa cells were seeded in a 96-well plate
at 3  103 cells in 100 mL DFCS/well on the day prior to NP
treatment. Subsequently, DNA-loaded H3gT and (HR)3gT
peptide nanoparticles and nanoparticles without DNA-payload
were added to each well to a final concentration of 50, 300, 550,
800, 1050, 1300, 1550 mg mL1. Untreated cells were used as
a reference value for 100% viability. All experiments were
performed in triplicate wells for each condition and repeated
at least twice. After 24 h of incubation at 37 1C, 20 mL of MTS
solution were added to each well, and the plate incubated for
2 h at 37 1C. The absorbance of the plate was then read at
l = 490 nm using a Spectramax plate reader (Molecular Devices
LLC, USA). Background absorbance of wells without cells was
subtracted from all test wells. The viability in treated wells was
determined by normalizing the absorbance to that of untreated
control cells.
Cellular uptake of MCM-NPs. Histone H2B-GFP expressing
HeLa cells (3  104 cells per well) were seeded in DMEM
medium supplemented with 10% FCS on a m-slide eight-well
glass-bottom plate (Ibidi, Germany). After 24 h, 40 mL of DNA-
loaded peptide nanoparticles were added to each well. After 6 h
incubation at 37 1C, the cell culture medium was replaced with
fresh medium and cells were incubated for another 18 h. Prior
to live cell imaging, cells were washed four times with PBS and
300 mL Invitrogent live cell imaging solution (ThermoFisher)
were added. Cells were imaged on a Zeiss LSM 880 confocal
laser-scanning microscope (CLSM) at 24 h and again at 48 h
using the same image acquisition settings for treated and
untreated cells. Furthermore, cells treated with 100 bp dsDNA
were imaged over 42 h under live cell conditions (37 1C, 5% CO2).
Results and discussion
Characterization of DNA-free and DNA-loaded peptide
MCM-NPs
The urgent need for a versatile non-viral delivery system with
advanced physicochemical characteristics that allows for the
eﬃcient incorporation of DNA other than single-stranded short
antisense oligonucleotides motivated us to develop a purely
peptidic DNA delivery system that self-assembles. To system-
atically explore the molecular parameters that are associated
with producing such a DNA-delivery system, we designed a 19
amino acid amphiphilic peptide henceforth termed (HR)3gT
(Fig. 1A). The core of the peptide is based on a 10 amino acid
amphiphilic H3gT peptide, which has previously been shown to
self-assemble into multi-compartment micellar nanoparticles
(MCM-NPs) when employing the solvent exchange method.50
To accommodate the negative charge of DNA segments during
self-assembly, the positive charge of the hydrophilic domain
was increased by adding an arginine residue after each histidine.
The extension of the hydrophilic domain was compensated
by increasing the hydrophobic domain of H3gT from three to
six repetitive L-tryptophan-D-leucine [LW-DL] motifs in (HR)3gT
(Fig. 1A) as the ratio of hydrophilic to hydrophobic domain is a
critical determinant for the assembly of micelles.54,55 The newly
designed (HR)3gT peptide and the 10 amino acid H3gT (for
comparison) were synthesised using standard Fmoc-based solid
phase peptide synthesis and purified by RP-HPLC. MALDI-TOF
mass spectrometry confirmed the expected molecular mass of
2878 gmol1 for purified (HR)3gT and 1512.7 g mol1 for purified
H3gT (Fig. S2, ESI†). The addition of the hydrophilic and hydro-
phobic residues in (HR)3gT might interfere with the ability to
form nanoparticles although the weight ratio between hydrophilic
and hydrophobic domains was kept in the range that typically
leads to micelle formation. Thus, we tested the self-assembly of
(HR)3gT under the same solvent exchange conditions as reported
for H3gT. An overview transmission electron microscopy (TEM)
image (Fig. S3A, ESI†) showed that (HR)3gT NPs had a similar
appearance. (HR)3gT assembled MCM-NPs with a morphology
similar to that observed for H3gT (Fig. 1B). Intriguingly, (HR)3gT
MCM-NPs appeared slightly smaller than H3gT MCM-NPs in
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negatively stained specimens. Consistent with this notion, analysis
of particle size by DLS showed a shift from DH = 211  46 nm
for H3gT (Table S2, ESI†) to DH = 112  21 nm for (HR)3gT
(Fig. 1B, right panel). Further evidence for the assembly
of several micelles into a multicompartment structure was
provided by high resolution TEM of an individual nanoparticle
(Fig. S3B, ESI†).
To optimize the yield of (HR)3gT MCM-NP formation and
simultaneously entrap 22 nt ssDNA during their self-assembly,
we performed the solvent exchange at 4 1C to diﬀerent final
ethanol concentrations (Fig. S4, ESI†). Formation of MCM-NPs
was observed at final concentrations of 35% and 50% ethanol,
while at 20% ethanol, predominantly individual micelles and
smaller MCM-NPs were detected with few contaminants of
un-assembled peptide. However, at 50% ethanol concentration,
the 22 nt single stranded DNA precipitated rather than being
entrapped into the MCM-NPs as revealed by precipitation of
fluorescently labelled DNA to the bottom of dialysis tube.
Hence, 35% ethanol was chosen as a final solvent concentration
to allow for DNA incorporation into self-assembled MCM-NPs.
Ultrastructural analysis by TEM showed that in the presence
of 22 nt ssDNA, the newly designed (HR)3gT peptide assembled
NPs with a multi-compartment micellar architecture similar to
that of H3gT MCM-NPs (Fig. 2A, upper panel). To test the ability
of (HR)3gT to entrap dsDNA, we examined (HR)3gT self-
assembly in the presence of 22 bp dsDNA and compared it to
H3gT (Fig. 2A, lower panel).
In contrast to H3gT peptide, the newly designed (HR)3gT
peptide was able to form spherical MCM-NPs also in the
presence of 22 bp dsDNA. Conceivably, the higher positive charge
of (HR)3gT in comparison to H3gT results in an increased
electrostatic interaction between the negatively charged DNA
and positively charged peptide. In addition, because dsDNA
is more rigid than ssDNA and has double the amount of
negatively charged phosphate in its backbone, it is likely to
require a higher driving force, i.e. more positive charges
that are available for the electrostatic interactions needed to
condense the stiﬀer dsDNA. To bridge the gap in DNA loading
between existing non-viral systems that deliver short single-
stranded ASO and those that are based on complex formation
to transfer entire genes, we assessed the self-assembly process
of (HR)3gT in the presence of single- and double-stranded DNA
sequences of 100 nucleotide length (Fig. 2B). While both 100 nt
ssDNA and 100 bp dsDNA were entrapped during the self-
assembly process of (HR)3gT, the shorter H3gT peptide was
not able to self-assemble into MCM-NPs in the presence of the
longer DNA segments. In the self-assembly solution at pH 7.1,
the net charge of the (HR)3gT peptide is +3 while H3gT has a
net charge of +0.3 with regard to their isoelectric point. Therefore,
H3gT peptide does not provide adequate positive charge to enable
electrostatic forces that condense the longer ss/dsDNA. Thus,
increasing the positive charge of hydrophilic domain of H3gT
by arginine is conducive to the entrapment of the longer DNA
segment in the (HR)3gT MCM-NPs. Although the hydrophilic to
hydrophobic weight ratio in (HR)3gT was slightly higher (44.6%
compared to 38.4%), it was still within the range where micelles
formed. Our data suggest that optimizing the charge and tuning
the ratio of hydrophilic to hydrophobic domains are key parameters
in the development of DNA delivery systems based on peptidic
MCM-NPs.
Fig. 1 Self-assembling amphiphilic (HR)3gT peptide. (A) The (HR)3gT peptide consists of a hydrophilic (green) and hydrophobic (purple) domain based
on modifications of the amphiphilic H3gT peptide (represented in black). The panel on the right is a schematic representation of the self-assembled
multi-compartment micelle nanoparticle. (B) TEM micrographs and DLS of (HR)3gT MCM-NPs and H3gT MCM-NPs, scale bars = 200 nm.
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Consistent with TEM analysis, the scattered intensities
measured by DLS demonstrated a narrow size distribution in
the range of 100–180 nm for all (HR)3gT assemblies (Fig. 2).
It is noteworthy that the average size for 22 nt ssDNA-loaded
(HR)3gT NPs was smaller than the corresponding H3gT NPs
(160  18 nm versus 241  73 nm in diameter). This can be
attributed to the higher charge interaction between the new
peptide and DNA resulting in more compacted NPs.
Furthermore, increasing the length of the entrapped DNA
sequence from 22 nt/bp to 100 nt/bp did not significantly aﬀect
the average size of (HR)3gT NPs. It is widely accepted that
particle size plays a critical role in developing successful
therapeutic delivery systems.56,57 For example, size is one of
the most crucial determinants of nanoparticle half-life. In order
to decrease the likelihood of liver or splenic trapping and
increase systemic circulation time, a particle size below 200 nm
is desired for in vivo applications of non-viral delivery systems.58
Thus, maintaining a particle size below 200 nm independent
of whether 22 nt/bp or 100 nt/bp were entrapped represents an
important advance of the (HR)3gT peptide towards an eﬃcient
DNA delivery system. Moreover, as the upper size limit for a
clathrin-mediated endocytosis is 200 nm,59,60 the charac-
teristic size of our newly generated DNA-loaded (HR)3gT
MCM nanoparticles make them well-suited for cellular uptake.
DLS and TEM demonstrated that (HR)3gT NPs with and without
DNA do not tend to aggregate over time. This is a further
advantage over H3gT peptide nanoparticles which tend to
aggregate.50
Fig. 2 TEM micrographs and DLS of (HR)3gT and H3gT MCM-NPs. (A) 22 nt ssDNA and 22 bp dsDNA loaded MCM-NPs, and (B) 100 nt ssDNA and
100 bp dsDNA loaded MCM-NPs. Scale bars = 200 nm.
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To determine the size and polydispersity index (PDI) of
(HR)3gT MCM-NPs that had entrapped either single- or double-
stranded DNA sequences of diﬀerent lengths, we employed DLS,
NTA and FCS measurements and compared the corresponding
data (Table 1). From the FCS measurements, we determined
the hydrodynamic radius of NPs from eqn (4) (see Methods)
and extracted the diﬀusion time by solving eqn (2), using the
hydrodynamic diameter and the known diﬀusion coeﬃcients of
ss/dsDNA of diﬀerent size.61
In addition, the surface charge of nanoparticles is known to
play a key role in cellular uptake. In many instances, positively
charged particles were shown to be eﬃciently endocytosed due
to their interactions with the negatively charged cell membrane.62,63
Accordingly, the zeta potentials of empty and DNA-loaded (HR)3gT
MCM-NPs were measured (Table 1).
A PDIr 0.3, which for polymer-based nanosystems implies
a relatively monodisperse system, was obtained by DLS measure-
ments of DNA-free and DNA-loaded (HR)3gT MCM-NPs.64,65
It is noteworthy that (HR)3gT MCM-NPs (DNA-free and DNA-
loaded) had a lower PDI than corresponding H3gT MCM-NPs
(Table S2, ESI†). The mean diameter obtained by NTA was
similar that determined by DLS for each kind of (HR)3gT
MCM-NPs (Table 1). The respective sizes were further corro-
borated by average sizes calculated from FCS measurements
(Table 1). Indeed, FCS is a suitable method for characterizing
the size of fluorescent NPs if the number of fluorescent species
isr3 and the particle sizeo500 nm.53 In contrast to the hydro-
dynamic diameters of (HR)3gT MCM-NPs loaded with diﬀerent
DNAs, which were all below 200 nm, H3gT MCM-NPs loaded
with 22 nt ssDNA were above 200 nm in diameter (Table S2,
ESI†), which also limited their cellular uptake (see below,
Fig. 7). It has been reported that nanoparticles above 200 nm
may be excluded from cellular internalization altogether.66,67
With the entrapment of negatively charged DNA in self-
assembling (HR)3gT the surface charge of the resulting MCM-
NPs only slightly decreased compared to DNA-free NPs. These
data support the presence of corresponding DNA payload
between individual micelles of the multi-compartment rather
than its accumulation on the NP surface (Table 1) which would
lead to larger decrease of the zeta potential. As expected, in the
absence of DNA, (HR)3gT MCM-NPs displayed a higher zeta
potential than H3gT MCM-NPs (Table 1 and Table S2, ESI†)
due to the extra arginines included in the hydrophilic domain
of (HR)3gT. With a surface charge of 2.8  3.35 mV, 22 nt
ssDNA-loaded (HR)3gT MCM-NPs experience repulsion forces
between each other that hinder their aggregation. On the
other hand, 22 nt ssDNA-loaded H3gT MCM-NPs are neutral
(0.6  2.3 mV) and thus, tend to aggregate after formation.
A positive surface charge has been shown to be advantageous
for delivering DNA in a number of NP systems.68 For example,
PEGylated DNA/transferrin–PEI complexes bearing a positive
charge of only +4 mV, were found to be the most efficient gene
delivery system among other positively charged complexes.69
In another study on 140 distinct polymer compositions,
DNA-loaded NPs bearing a charge of +1.8 mV demonstrated
the third highest uptake and best overall transfection of a
luciferase plasmid in NIH 3T3 cells.70 Accordingly, the overall
positive charge of +2mV to +4 mV of (HR)3gT MCM-NPs
loaded with different DNA segments is expected to be con-
ducive to an efficient DNA delivery. Thus, the modifications
of our newly designed (HR)3gT peptide, which led to MCM-
NPs below 200 nm with a slightly positive surface charge,
represent a crucial advance in fulfilling the physiochemical
criteria required for generating successful therapeutic nano-
systems.
Quantification of DNA entrapped in (HR)3gT MCM-NPs
The incorporation of diﬀerent sizes and types of DNA into
(HR)3gT MCM-NPs was examined by FCS using Atto550-labelled
DNAs. Diﬀusion time (tD) and count per molecule (CPM) of free
Atto550 dye, Atto550-DNA in solution, and of Atto550-DNA-loaded
(HR)3gT MCM-NPs were calculated by fitting the experimental
autocorrelation curves (Fig. 3) to a two-component fit (eqn (1)).
Subsequently, the number of DNA molecules per particle was
calculated by dividing the CPM of DNA-loaded (HR)3gT MCM-
NPs by the corresponding Atto550-DNA in solution (Table 2). The
significant increase in the diﬀusion time of all Atto550-DNA-
loaded NPs compared to Atto550-labelled DNA indicates that the
DNA is entrapped in (HR)3gTMCM-NPs. For (HR)3gTMCM-NPs,
we calculated 19.9  13.7 22 nt ssDNA molecules per particle
while the H3gT peptide was able to entrap 3.95  2.39 22 nt
ssDNA per particle. Although 22 nt ssDNA-loaded (HR)3gT
MCM-NPs had entrapped five times more 22mer ssDNA than
H3gT MCM-NPs, their average size is significantly smaller
(160  18 versus 241  73 nm, Table 1, p r 0.05) (Table 2 and
Table S3, ESI†). Hence, the enhanced positive charge of (HR)3gT
peptide compared to H3gT peptide results in increased electro-
static interactions between DNA and peptide and more compact
assemblies. Consequently, the nanoparticle size remains smaller
than the corresponding H3gT MCM-NPs despite more DNA
and a longer peptide (19 versus 10 amino acids). For (HR)3gT
MCM-NPs loaded with double-stranded 22 bp DNA, the average
Table 1 Characterization of DNA-free and DNA-loaded (HR)3gT MCM-NPs, suspended in water, pH 7
(HR)3gT MCM-NPs PDI DH
a (nm) DLS DH (nm) NTA DH (nm) FCS Zeta potential (mV)
(HR)3gT NPs 0.19  0.024 112  21 102  6 N/A +8.2  2.1
22 nt ssDNA loaded (HR)3gT NPs 0.23  0.026 160  18 151  12 144  58 +2.8  3.35
22 bp dsDNA loaded (HR)3gT NPs 0.22  0.023 115  19 129  10 124  62 +3.67  3.11
100 nt ssDNA loaded (HR)3gT NPs 0.28  0.021 176  11 164  4 186  78 +3.46  3.87
100 bp dsDNA loaded (HR)3gT NPs 0.27  0.02 165  12 150  11 174  99 +4.18  3.36
a DH is a hydrodynamic diameter.
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diﬀusion time of 3235  1607 ms indicated that the number of
DNA molecules per particle is approximately half the number
of corresponding ssDNA per particle (Fig. 3B and Table 2).
Considering that electrostatic interactions between DNA and
peptide are responsible for the DNA entrapment during the
self-assembly process, doubling the amount of negatively
charged phosphates in the backbone of the double-stranded
DNA may explain why the entrapment is reduced by half.
In addition, the higher rigidity of the 22 bp dsDNA may
interfere with entrapment.
Likewise, for the longer DNA segments (100 nt/bp ss/dsDNA),
the number of DNA molecules incorporated into (HR)3gT
MCM-NPs decreased compared to both, single- and double-
stranded 22 nucleotide-long DNA (Fig. 3C, D and Table 2).
(HR)3gT with an isoelectric point of 12.4 (versus 7.61 for H3gT)
has a charge of +3 compared to 0 for H3gT at neutral pH.
Because more electrostatic interactions that drive the DNA
incorporation can occur, (HR)3gT is able to condense longer
DNA segments (100 nt and 100 bp). Thus, the modifications of
the (HR)3gT peptide, in particular the enhanced positive charge
over H3gT, conveys not only the ability to entrap longer single-
and double-stranded DNA upon nanoparticles but also the
potential to more eﬃciently incorporate higher amounts of
22 nt ssDNA. Generating (HR)3gT MCM-NPs with improved
DNA loading and smaller particle size compared to H3gT
represents a significant progress towards developing an eﬃ-
cient and functional DNA delivery system.
Determination of MCM-NP concentrations by NTA
The total concentration of particles in solution and the percen-
tage of loaded particles were determined by nanoparticle
tracking analysis (Table 3). The concentration of MCM-NPs
formed in the presence of 100 nt long sequences was similar
for single- and double-stranded DNA (3.29  108  7.65 
107 mL1 and 3.34  108  8.64  107 mL1, respectively), and
comparable to that of NPs assembled in the presence of 22 bp
dsDNA (3.02  108  3.06  107 mL1). Significantly higher
numbers of MCM-NPs (5.57  108  7.03  107) were obtained
when (HR)3gT was assembled with 22 nt ssDNA. For all types
of DNA, more than 60% of the MCM-NPs were loaded with
DNA whereby the percentage of loaded particles for dsDNA
(22 bp and 100 bp) was clearly higher than for ssDNA (22 nt and
100 nt). Considering the FCS data presented above, which show
that (HR)3gT MCM-NP entrap approximately twice as many
ssDNA as dsDNA molecules, the overall amount of loaded DNA
is higher for ssDNA compared to dsDNA MCM-NPs. Thus, while
the total concentration of particles is similar for 100 nt ssDNA
and 100 bp dsDNA MCM-NPs, the overall amount of entrapped
DNA is higher with single-stranded than with double-stranded
DNA despite the lower percentage of loaded particles (68.5%
versus 82%). Similarly, the percentage of loaded particles for the
22 nt long DNA was 68.5% for ssDNA versus 95% for dsDNA
(3.82  108  2.29  107 versus 2.87  108  3.10  107). Due to
the significantly higher concentration of MCM-NPs that self-
assemble in the presence of 22 nt ssDNA, the diﬀerence in
the amount of entrapped DNA between single- and double
stranded is higher for 22 nucleotide long DNA sequences than
for 100 nucleotide sequences.
The stability of DNA-free and DNA-loaded (HR)3gT MCM-NPs
To obtain insight on the stability of DNA-free and DNA-loaded
(HR)3gT peptide NPs, we analyzed the size of NPs stored at 4 1C
by DLS over time (Fig. 4A). Nanoparticle size measurements
recorded every 30 days indicated that the average diameter of
DNA-free and DNA-loaded (HR)3gT MCM-NPs did not change
over five months. TEM analyses of empty and DNA-loaded
(HR)3gT MCM-NPs after 5 months (Fig. 4B) showed that
nanoparticles retained their initial multi-compartment micellar
Fig. 3 Normalised FCS autocorrelation curves for (A) Atto550-labelled 22 nt ssDNA (dark green), 22 nt ssDNA-loaded (HR)3gT MCM-NPs (green),
(B) Atto550-labelled 22 bp dsDNA (dark blue), 22 bp dsDNA-loaded (HR)3gT MCM-NPs (blue), (C) Atto550-labelled 100 nt ssDNA (brown), 100 nt ssDNA-
loaded (HR)3gT MCM-NPs (orange), (D) Atto550-labelled 100 bp dsDNA (dark purple), 100 bp dsDNA-loaded (HR)3gT MCM-NPs (purple). Atto550 free
dye is shown in red in all panels.
Table 2 Quantification of DNA loading in to (HR)3gT MCM-NPs by FCS
Fluorescent specious
Diﬀusion
time (ms) DNA/particle
Atto550 fluorescent dye 48  3 N/Aa
Atto550 labelled 22 nt ssDNA 139  5 N/A
Atto550 labelled 22 bp dsDNA 157  9 N/A
Atto550 labelled 100 nt ssDNA 237  13 N/A
Atto550 labelled 100 bp dsDNA 283  12 N/A
22 nt ssDNA loaded (HR)3gT MCM-NPs 3894  1337 19.9  13.7
22 bp dsDNA loaded (HR)3gT MCM-NPs 3235  1607 11.7  7.2
100 nt ssDNA loaded (HR)3gT MCM-NPs 3875  1778 2.12  2.43
100 bp dsDNA loaded (HR)3gT MCM-NPs 3553  1900 1.47  1.12
a Not applicable.
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Table 3 Nanoparticle tracking analysis of DNA-free and DNA-loaded (HR)3gT MCM-NPs
MCM peptide NPs
Total concentration
(particles per mL)
Concentration of labelled
particles (particles per mL)
Loaded
particles (%)
(HR)3gT NPs 4.29  108  9.17  107 N/A N/A
22 nt ssDNA loaded (HR)3gT NPs 5.57  108  7.03  107 3.82  108  2.29  107 68.5
22 bp dsDNA loaded (HR)3gT NPs 3.02  108  3.06  107 2.87  108  3.10  107 95
100 nt ssDNA loaded (HR)3gT NPs 3.29  108  7.65  107 2.25  108  1.10  107 68.3
100 bp dsDNA loaded (HR)3gT NPs 3.34  108  8.64  107 2.74  108  1.52  107 82
Fig. 4 Stability of (HR)3gT MCM-NPs. From top to bottom: (A) DLS over 150 days, and (B) TEM after 150 days for (HR)3gT MCM-NPs, 22 nt ssDNA-loaded
(HR)3gT MCM-NPs, 22 bp dsDNA-loaded (HR)3gT MCM-NPs, 100 nt ssDNA-loaded (HR)3gT MCM-NPs, and 100 bp dsDNA-loaded (HR)3gT MCM-NPs.
Scale bars = 200 nm.
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structure. In contrast, H3gtT MCM-NPs, especially when loaded
with 22 nt ssDNA, aggregated due to their neutral surface charge.50
Thermo-responsiveness of DNA-free and DNA-loaded (HR)3gT
MCM-NPs
To assess thermo-responsiveness, DNA-free and DNA-loaded
(HR)3gT MCM-NPs were incubated at 37 1C for 5 h and 24 h.
Ultrastructural analysis by TEM revealed that compared to the
MCM structure of NPs at 4 1C, (HR)3gT MCM-NPs disassembled
into smaller MCMs and/or individual micelles after 5 h at 37 1C
(Fig. 5A). The tendency to disassembly increased over time and
after 24 h at 37 1C (Fig. 5B), only few MCM-NPs were detected.
When kept at 37 1C, all peptide MCM-NPs exhibited a similar
trend in the change of their structure and size, independent
of the length and type (single or double stranded) of the
entrapped DNA, whereas at 4 1C, (HR)3gT MCM-NPs remained
stable for as long as 5 months (Fig. 4). Likewise, H3gT MCM-
NPs demonstrated a similar disassembly behaviour in response
to temperature (Fig. S6, ESI†). Our data are consistent with
the study by Schuster et al. who reported that the formation of
MCM peptide NPs occurs as a function of temperature and
solvent composition.71
Eﬀect of (HR)3gT MCM-NPs on cell viability
In order to examine the cytotoxicity of our non-viral DNA delivery
system, MTS cell proliferation assays with diﬀerent concentra-
tions of DNA-loaded and DNA-free (HR)3gT MCM-NPs (up to
1550 mg mL1) were evaluated (Fig. 6). The data showed that after
24 h of incubation at 37 1C, DNA-loaded and DNA-free (HR)3gT
MCM-NPs up to a concentration of 1550 mg mL1 had no toxic
eﬀects on HeLa cells. Interestingly, 22 nt ssDNA-loaded (HR)3gT
MCM-NPs had no significant inhibitory eﬀect on cell prolifera-
tion even though they are loaded with a 5-times higher amount of
22 nt ssDNA compared to corresponding H3gT MCM-NPs (MTS
assays for H3gT MCM-NPs in Fig. S7, ESI†). These findings
suggest that the viability of treated cells remains largely
unaﬀected by the peptide MCM-NP concentration and the
amount of entrapped DNA. Based on the apparent biocompati-
bility, (HR)3gT MCM-NPs are a viable candidate for the future
development of safe gene delivery systems.
Cellular uptake
The cellular uptake of peptide MCM-NPs loaded with fluores-
cently labelled Atto550-DNA segments was examined in H2B-GFP
Fig. 5 TEM micrographs of (HR)3gT MCM-NPs with diﬀerent DNA loads after (A) 5 h incubation, and (B) 24 h incubation at 37 1C. Scale bars = 200 nm.
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expressing HeLa cells by confocal laser scanning microscopy
(CLSM). We first compared cells that were treated with 22 nt
ssDNA-loaded (HR)3gT or H3gT MCM-NPs (Fig. 7A). Confocal
images of cells incubated with NPs for 24 h revealed that at a
similar cell density, a significantly higher number of cells had
taken up 22 nt ssDNA-loaded (HR)3gT MCM-NPs. Besides the
higher rate of uptake, the fluorescence signal in these cells was
considerably stronger than in cells containing H3gT MCM-NPs
under identical imaging conditions. Also after 48 h of NP
incubation, the uptake eﬃciency for 22 nt ssDNA-loaded
(HR)3gT was higher than for H3gT MCM-NPs (Fig. S8, ESI†).
Several properties of NPs assembled from the newly designed
(HR)3gT peptide could account for the higher uptake eﬃciency
of 22 nt ssDNA-loaded (HR)3gT MCM-NPs versus 22 nt ssDNA-
loaded H3gT MCM-NPs. Nanoparticle size, shape, surface
charge, and surface functionality are known to aﬀect cellular
uptake.70,72 Based on literature reports, the optimal size for NP
uptake, especially in cancer treatment, is between 70–200 nm
and ideally close to 100 nm. However, for specific applications,
slightly larger particle sizes may be more advantageous.73–77
Accordingly, 22 nt ssDNA-loaded (HR)3gT MCM-NPs with the
mean diameter of 160  18 nm are in range for optimal uptake
in contrast to 22 nt ssDNA-loaded H3gT MCM-NPs (241 
73 nm). Furthermore, the increased cellular uptake could be
facilitated with other internalization mechanisms because
of arginine–histidine repeating units that are exposed on
the hydrophilic surface of the MCM-NPs. Numerous studies
report that arginine residues promote cell penetration and
increase internalization efficiency in the delivery of thera-
peutic macromolecules, in particular nucleic acids.78–86 For
example, using a multifunctional envelope-type nanodevice
(MEND) that comprises an octa-arginine as a gene delivery
system resulted in an improvement in gene expression by
more than 300 times compared to an unmodified MEND.87
Besides a larger number of (HR)3gT MCM-NPs taken up per
cell, the increased fluorescence intensity is also related to the
5 times higher amount of 22 nt ssDNA loaded per particle
compared to H3gT MCM-NPs.
Cellular uptake assays with (HR)3gT MCM-NPs loaded with
22 bp dsDNA and longer sequences (100 nt/bp) revealed a
similarly high uptake eﬃciency for all (HR)3gT MCM-NPs
(Fig. 7B). As previously mentioned, the number of incorporated
dsDNA molecules/particle is approximately half compared to
the number of ssDNA molecules in corresponding (HR)3gT
MCM-NPs. Thus, under identical imaging conditions, one can
expect a lower fluorescence signal for dsDNA-loaded peptide NP
uptake. However, CLSM images showed no significant diﬀer-
ence between 22 bp dsDNA and 22mer ssDNA-loaded (HR)3gT
MCM-NPs (compare Fig. 7A and B), and between 100 bp dsDNA
and 100mer ssDNA-loaded MCM-NPs (Fig. 7B). It is possible
that small diﬀerences in size and surface charge between MCM-
NPs loaded with dsDNA versus ssDNA (see Table 1) lead to an
increase in cellular uptake and thus, account for the greater
fluorescence signal. Furthermore, a time-dependent increase of
intracellular fluorescence from 1 to 13h for 100 bp dsDNA-
loaded (HR)3gT MCM-NPs is shown in Fig. 7C (the corres-
ponding time-lapse video is available as ESI†). Although in vitro
analysis of thermo-responsiveness showed a disassembly of
MCM-NPs after 5 h, earlier time points, i.e. 1 and 2 h, revealed
that the multicompartment micellar architecture of 100 bp
dsDNA-loaded (HR)3gT NPs was still intact (Fig. S10A, ESI†).
Moreover, the analysis of cells incubated with dsDNA-loaded
(HR)3gT NPs showed that uptake occurred within an hour
(Fig. S10B, ESI†), which suggests that at least some of the
MCM-NPs are taken up before disassembly. Conceivably,
the time-course of MCM-NP thermo-responsiveness adds to
the release of DNA inside the cell. Our data suggest that the
type of the DNA sequence (i.e. single-stranded or double-
stranded) and the length (22 or 100 nucleotides) aﬀect the
assembly of MCM-NPs and consequently their cellular uptake
properties. Thus, to ultimately achieve a safe and eﬃcient
delivery system for protein encoding genes, the size of the
Fig. 6 HeLa cell viability (MTS assay). Cells treated for 24 h with (HR)3gT MCM-NPs (pink), 22 nt ssDNA-loaded (HR)3gT MCM-NPs (green), 22 bp
dsDNA-loaded H3gT MCM-NPs (blue), 100 nt ssDNA-loaded (HR)3gT MCM-NPs (orange), 100 bp dsDNA-loaded (HR)3gT MCM-NPs (purple).
Cell viability was normalized to untreated HeLa cells (negative control, 100% viability). All data presented as the mean  SD (n = 3).
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DNA will need to be successively increased and tested for its
eﬀects on the self-assembly behaviour of the (HR)3gT peptide.
It is possible that further modifications of the peptide design
might be necessary to accommodate for longer DNA sequences.
Conclusion
In this study, we addressed the challenge of developing an
eﬃcient and safe non-viral delivery system for DNA sequences
larger than the average antisense oligonucleotide. Specifically, we
established for the first time a purely peptidic self-assembling
MCM-NP that is able to entrap single- and double-stranded DNA
of 100 nucleotides/base pairs. We rationally designed and synthe-
sized the amphiphilic (HR)3gT peptide where we significantly
modified a short H3gT peptide by (i) increasing the charge of the
hydrophilic domain and (ii) extending the hydrophobic domain
to achieve a ratio that typically leads to the self-assembly of
micellar nanostructures. The comprehensive analysis of the
physicochemical characteristics of (HR)3gT MCM-NPs in the
presence of diﬀerent DNA cargoes indicates that the entrapment
is primarily governed by electrostatic interactions between DNA
and peptide, and the solvent conditions used for self-assembly.
Based on the amino acid modifications, (HR)3gT peptide was
able to entrap single- and double-stranded DNA sequences of
100 nucleotides whereas the short H3gT MCM-NPs could only
entrap 22 nt ssDNA. A thermodynamically stable system was
obtained, in which the sum of diﬀerent factors including chain
stretching, interfacial tension, and repulsive interactions
between hydrophilic domains, especially in the presence of
negatively charged DNA are minimized. Moreover, the addition
of arginine residues facilitated the crossing of biological
barriers, which points to a great potential of (HR)3gT MCM-NPs
for non-viral gene-delivery applications. (HR)3gT MCM-NPs with
diﬀerent DNA loads maintained a stable size and multi-
compartment micellar structure over five months at 4 1C,
but disintegrated into smaller MCMs and/or individual
micelles at 37 1C. The thermo-responsiveness, together with
the low cell toxicity and rapid cellular uptake, constitute
essential features in the eﬃcient delivery of the DNA seg-
ments. In addition, the possibility of chemical modification by
variation of their amino acid sequence and composition
renders peptide nanoparticles easily tunable compared to
lipid nanoparticles. Taking into account these advantages,
our (HR)3gT non-viral DNA delivery system provides the first
stepping stone towards developing a purely peptide-based
self-assembling nanostructure for the delivery of entire genes.
Future designs will need to address several parameters,
Fig. 7 CLSM merged images (GFP and Atto550) of H2B-GFP expressing HeLa cells treated with (A) 22 nt ssDNA-loaded H3gT and (HR)3gT MCM-NPs,
and (B) 22 bp and 100 nt/bp ss/dsDNA-loaded (HR)3gT NPs after 24 h. (C) Time course of 100 bp dsDNA-loaded (HR)3gT MCM NP uptake. Scale bars =
20 mm.
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e.g. nuclear targeting, to optimize the delivery eﬃciency of
peptidic MCM-NPs for medical applications.
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